Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025)
Benitec Biopharma's (BNTC) quarterly Other Non-Current Assets came in at $11000.0 in Q4 2025, down 45.0% quarter-over-quarter from $20000.0 in Q3 2025.
Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Benitec Biopharma has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $11000.0 for Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $11000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $11000.0 (changed N/A YoY), and the FY2025 annual result was $55000.0, up 120.0% from the prior year.
- Other Non-Current Assets came in at $11000.0 for Q4 2025 at Benitec Biopharma, down from $20000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $567000.0 in Q3 2023 to a low of $9000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $25000.0 (2021), against an average of $133105.3.
- Across the five-year window, Other Non-Current Assets jumped 5444.44% in 2021 and sank 94.99% in 2022, its largest moves.
- Benitec Biopharma's Other Non-Current Assets stood at $499000.0 in 2021, then tumbled by 94.99% to $25000.0 in 2022, then surged by 1644.0% to $436000.0 in 2023, then plunged by 87.16% to $56000.0 in 2024, then plunged by 80.36% to $11000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $11000.0 (Q4 2025), $20000.0 (Q3 2025), and $55000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Benitec Biopharma | 478.55 Mn | 478.55 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 436,000.00 |
| Sep 30, 2023 | 567,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 362,000.00 |
| Dec 31, 2021 | 499,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 185,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |